SOL-1 Phase 3 Data Presentation at AAO with New Data Analysis Download Presentation 662.7 KB SOL-1 Phase 3 Data Presentation at Euretina Download Presentation 10.2 MB Watch By Chapter Investor Day 2026 Download Presentation 6.4 MB Listen to the Full Presentation Watch Full Video Watch Investor Day by Chapter1.) Intro & Overview (Pravin U. Dugel, MD)2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)5.) Preparing for a Successful Launch (David Robinson)6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)8.) Summary & Takeaways (Pravin U. Dugel, MD)9.) Audience Q&A (All) SOL-1 Phase 3 Data Presentation at Macula Society Download Presentation 6.6 MB Watch Full Video Watch By Chapter
1.) Intro & Overview (Pravin U. Dugel, MD)2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)5.) Preparing for a Successful Launch (David Robinson)6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)8.) Summary & Takeaways (Pravin U. Dugel, MD)9.) Audience Q&A (All)
1.) Intro & Overview (Pravin U. Dugel, MD)2.) SOL-1 Data & Clinical Program Review (Nadia K. Waheed, MD, MPH)3.) U.S. Regulatory Strategy in Wet AMD (Peter K. Kaiser, MD)4.) NDA Submission Strategy (Peter K. Kaiser, MD & Arthur Ciociola, PhD)5.) Preparing for a Successful Launch (David Robinson)6.) SOL-R- Defining Non-Inferiority Success (Jeffrey S. Heier, MD)7.) KOL Perspectives (Featuring Arshad Khanani, MD; Lejla Vajzovic, MD; Darius Moshfeghi, MD)8.) Summary & Takeaways (Pravin U. Dugel, MD)9.) Audience Q&A (All)
